Trials / Completed
CompletedNCT00160160
Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
A Multi-Center, Double-Blind, Randomized Study Comparing the Efficacy of Combination Therapy of Eprosartan Respectively Ramipril With Low-Dose Hydrochlorothiazide and Moxonidine on Blood Pressure Levels in Patients With Hypertension and Associated Diabetes Mellitus Type 2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 440 (planned)
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | eprosartan/HCTZ |
Timeline
- Start date
- 2004-10-01
- First posted
- 2005-09-12
- Last updated
- 2009-01-30
Locations
63 sites across 9 countries: Canada, Denmark, France, Germany, Italy, Norway, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00160160. Inclusion in this directory is not an endorsement.